Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf-Rüdiger Schäbitz

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Stroke|July 4, 2013
Regulatory T cells in ischemic stroke: helpful or hazardous?Wolf-Rüdiger Schäbitz
Stroke|June 6, 2009
MR mismatch is useful for patient selection for thrombolysis: noWolf-Rüdiger Schäbitz
Neural Regeneration Research|September 24, 2021
Embolic stroke of undetermined source: identification of patient subgroups for oral anticoagulation treatmentIsabell Greeve, Wolf-Rüdiger Schäbitz
The New England Journal of Medicine|February 27, 2010
Darbepoetin alfa and chronic kidney diseaseJens Minnerup, Wolf-Rüdiger Schäbitz
Stroke|April 19, 2014
Are we ready to translate T-cell transmigration in stroke?Wolf-Rüdiger Schäbitz, Ulrich Dirnagl
Experimental & Translational Stroke Medicine|February 10, 2010
Time to overcome the translational roadblock: Introducing a new open access stroke journalWolf-Rüdiger Schäbitz, Christoph Kleinschnitz
Trends in Pharmacological Sciences|March 14, 2007
New targets for established proteins: exploring G-CSF for the treatment of strokeWolf-Rüdiger Schäbitz, Armin Schneider
Stroke|August 20, 2011
Chronic kidney disease and alcohol consumption: are asians at particular risk for hemorrhagic stroke?Wolf-Rüdiger Schäbitz, Holger Reinecke
Neurological Research and Practice|February 14, 2025
Neurological Research and Practice - the premier journal of the German Society of Neurology: recent development and future perspectivesWerner Hacke, Wolf-Rüdiger Schäbitz
Neural Regeneration Research|September 2, 2021
Stroke recovery enhancing therapies: lessons from recent clinical trialsAndreas Rogalewski, Wolf-Rüdiger Schäbitz
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Stroke|July 4, 2013
Regulatory T cells in ischemic stroke: helpful or hazardous?Wolf-Rüdiger Schäbitz
Stroke|June 6, 2009
MR mismatch is useful for patient selection for thrombolysis: noWolf-Rüdiger Schäbitz
Neural Regeneration Research|September 24, 2021
Embolic stroke of undetermined source: identification of patient subgroups for oral anticoagulation treatmentIsabell Greeve, Wolf-Rüdiger Schäbitz
The New England Journal of Medicine|February 27, 2010
Darbepoetin alfa and chronic kidney diseaseJens Minnerup, Wolf-Rüdiger Schäbitz
Stroke|April 19, 2014
Are we ready to translate T-cell transmigration in stroke?Wolf-Rüdiger Schäbitz, Ulrich Dirnagl
Experimental & Translational Stroke Medicine|February 10, 2010
Time to overcome the translational roadblock: Introducing a new open access stroke journalWolf-Rüdiger Schäbitz, Christoph Kleinschnitz
Trends in Pharmacological Sciences|March 14, 2007
New targets for established proteins: exploring G-CSF for the treatment of strokeWolf-Rüdiger Schäbitz, Armin Schneider
Stroke|August 20, 2011
Chronic kidney disease and alcohol consumption: are asians at particular risk for hemorrhagic stroke?Wolf-Rüdiger Schäbitz, Holger Reinecke
Neurological Research and Practice|February 14, 2025
Neurological Research and Practice - the premier journal of the German Society of Neurology: recent development and future perspectivesWerner Hacke, Wolf-Rüdiger Schäbitz
Neural Regeneration Research|September 2, 2021
Stroke recovery enhancing therapies: lessons from recent clinical trialsAndreas Rogalewski, Wolf-Rüdiger Schäbitz
Pageof 16